References
- Allémann E, Gurny R, Doelker E. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: Influence of process parameters on particle size. International Journal of Pharmacology 1992; 87: 247–254
- Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews 1997; 28: 5–24
- Arechabala B, Coiffard C, Rivalland P, Coiffard LJ, De Roeck-Holtzhauer Y. Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test MTT assay and LDH release. Journal of Applied Toxicology 1999; 19: 163–165
- Bain DF, Munday DL, Smith A. Solvent influence on spray-dried biodegradable microspheres. Journal of Microencapsulation 1999; 16: 453–474
- Bazile D, Prudhomme C, Bassoullet MT, Marlard M, Spenlehauer G, Veillard M. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. Journal of Pharmaceutical Sciences 1995; 84: 493–498
- Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Preparation and characterization of poly (DL-lactide-co-glycolide) microspheres for controlled release of poly (L-lysine) complexed plasmid DNA. Pharmaceutical Research 1999; 16: 509–513
- Carver MP, Monteiro-Riviere NA, Brown TT, Riviere JE. Dose-response studies of gentamicin nephrotoxicity in rats with experimental renal dysfunction II. Polyvinyl alcohol glomerulopathy. Toxicology and Applied Pharmacology 1985; 80: 264–273
- Chacon M, Molpeceres J, Berges L, Guzman M, Aberturas MR. Stability and freeze-drying of cyclosporine loaded poly(DL lactide-glycolide) carriers. European Journal of Pharmaceutical Sciences 1999; 8: 99–107
- Chandy T, Das GS, Rao GHR. 5-fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. Journal of Microencapsulation 2000; 17: 625–638
- Chasin M, Langer R. Biodegradable polymers as drug delivery systems. M. Dekker, New York 1990; 347
- Couvreur P, Blancoprieto MJ, Puisieux F, Roques B, Fattal E. Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides (Review). Advanced Drug Delivery Reviews 1997; 28: 85–96
- Davis SS, Illum L. Polymeric microspheres as drug carriers. Biomaterials 1988; 9: 111–115
- De Chasteigner S, Cavé G, Fessi H, Devissaguet J-P, Puisieux F. Freeze-drying of itraconazole-loaded nanosphere suspensions: A feasibility study. Drug Development Research 1996; 38: 116–124
- Deng X, Liu Y, Yuan M, Li X, Liu L, Jia WX. Preparation and characterization of poly-DL-lactide-poly(ethylene glycol) microspheres containing DNA. Journal of Applied Polymer Sciences 2002; 86: 2557–2566
- Hu DSG, Liu HJ. Effect of soft segment on the degradation kinetics in polyethyleneglycol/poly(L-lactide) block copolymers. Polymer Bulletin 1993; 30: 669–676
- Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices [Review]. Biomaterials 2000; 21: 2475–2490
- Kawabata K, Takakura Y, Hashida M. The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake. Pharmaceutical Research 1995; 12: 825–830
- Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T. Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres. Journal of Controlled Release 1999; 62: 279–287
- Kissel T, Li LY, Volland C, Görich S, Koneberg R. Parenteral protein delivery systems using biodegradable polyesters of ABA block structure containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks. Journal of Controlled Release 1996; 39: 315–326
- Kwon HY, Lee JY, Choi SW, Jang YS, Kim JH. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method Colloids and Surfaces. A, Physicochemical and Engineering Aspects 2001; 182: 123–130
- Lemoine D, Deschuyteneer M, Hogge F, Preat V. Intranasal immunization against influenza virus using polymeric particles. Journal of Biomaterials Sciences, Polymer Edition 1999; 10: 805–825
- Martinez B, Lairion F, Pena MB, Di Rocco P, Nacucchio MC. In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres. Journal of Microencapsulation 1997; 14: 155–161
- Matsumoto J, Nakada Y, Sakurai K, Nakamura T, Takahashi Y. Preparation of nanoparticles consisting of poly(-lactide)-poly(ethylene glycol)-poly(-lactide) and their evaluation in vitro. International Journal of Pharmaceutics 1999; 185: 93–101
- Molpeceres J, Aberturas MR, Chacon M, Berges L, Guzman M. Stability of cyclosporine-loaded poly-ϵ-caprolactone nanoparticles. Journal of Microencapsulation 1997; 14: 777–787
- Nakada Y, Sakurai K, Horiushi M, Tudomi R, Nakamura T, Takahashi Y. Long-circulating nanoparticles using biodegradable ABA triblock copolymers containing of poly(-lactic acid) A-blocks attached to central poly(oxyethylene) B-blocks. Pharmaceutical Sciences 1997; 3: 1–4
- Quesnel R, Hildgen P. Synthesis and characterization of alternate (PLA-PEG-PLA)m multiblock copolymers. Proceedings of the 4th World Meeting ADRITELF/APGI/APV, Florence, April 8–11, 2002
- Quintanar-Guerrero D, Fessi H, Allémann E, Doelker E. Influence of stabilizing agents and preparative variables on the formation of poly(DL-lactic acid) nanoparticles by an emulsification-diffusion technique. International Journal of Pharmacology 1996; 143: 133–141
- Radwan MA, Zaghloul IY, Aly ZH. In vivo performance of parenteral theophylline-loaded polyisobutylcyanoacrylate nanoparticles in rats. European Journal of Pharmaceutical Sciences 1999; 8: 95–98
- Rizkalla N, Hildgen P, Thibert R. Influence of the fractal character of model substances on their reactivity at solid-liquid interfaces. Journal of Colloid and Interface Science 1999; 215: 43–53
- Ronneberger B, Kao WJ, Anderson JM, Kissel T. In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks. Journal of Biomedical Materials Research 1996; 30: 31–40
- Saez A, Guzmán M, Molpeceres J, Aberturas MR. Freeze-drying of polycaprolactone and poly(lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. European Journal of Pharmaceutics and Biopharmaceutics 2000; 50: 379–387
- Shah SS, Zhu KJ, Pitt CG. Poly(DL-lactic) acid-polyethylene glycol block copolymers. The influence of polyethylene glycol on the degradation of poly-DL-lactic acid. Journal of Biomaterials Science, Polymer Edition 1994; 5: 421–431
- Silvestri SL, Lostritto RT. Theoretical evaluation of dispersed droplet radii in submicron oil-in-water emulsions. International Journal of Pharmaceutics 1989; 50: 141–146
- Teraoka I. Polymer solutions: An introduction to physical properties. John Wiley & Sons Inc, New York 2002
- Thomasin C, Nam-Trân H, Merkle HP, Gander B. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations. Journal of Pharmaceutical Sciences 1998; 87: 259–268
- Yang YY, Chia HH, Chung TS. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Journal of Controlled Release 2000; 69: 81–96
- Youxin L, Kissel T. Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(L-lactic acid) or poly(L-lactic-co-glycolic) A-blocks attached to central poly(oxy-ethylene) B-blocks. Journal of Controlled Release 1993; 27: 247–257
- Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Advanced Drug Delivery Reviews 1995; 16: 61–73
- Zweers MLT, Grijpma DW, Engbers GHM, Feijen J. The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size. Journal of Biomedical Materials Research 2003; 66B: 559–566